“There were a couple of studies published last week that are worth bookmarking. They don’t tell us anything we don’t already know, but they contradict what a lot of people think they know. The first looks at smokeless tobacco and oral cancer risk. Gutkha, is strongly associated with oral cancer (partly because these products contain many other ingredients in addition to tobacco), but there is one notable exception. Snus was banned in the EU because it was assumed to have a similar risk profile to other smokeless products. It doesn’t. Not even close.
The other study looks at a remarkable feature of vaping – its extraordinary ability to help people quit smoking even when they have no intention of doing so. 12.7% of smokers quit smoking. Smokers not initially planning to quit within 6 months experienced higher odds of smoking cessation when they took up daily vaping (32.4%) versus no vaping (6.8%). The difference between a 6.8% quit rate and a 32.4% quit rate is enormous.“
Store
